SNORD53: A RNA-Binding Protein with Multiple Functions in The Brain and Immune System

Target Name: SNORD53

NCBI ID: G26796

SNORD53

Other Name(s): U53 | Small nucleolar RNA, C/D box 53 | RNU53 | small nucleolar RNA, C/D box 53 | SNORD53A

SNORD53: A RNA-Binding Protein with Multiple Functions in The Brain and Immune System

SNORD53 (U53) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of RNA-binding proteins known as Nucleotide-binding proteins (NBPs), which are a class of proteins that regulate gene expression by binding to specific nucleotide sequences.

SNORD53 is unique among NBP proteins in that it is expressed in the brain, where it is highly enriched, and in the heart and kidneys, where it is less abundant. It is also known to be involved in the regulation of gene expression in the brain , and is thought to play a role in the development and progression of certain neurological conditions.

One of the key functions of SNORD53 is its ability to interact with specific DNA sequences. It does this by using a unique feature, called a \"SNORD-like domain,\" which is present in the NBP family of proteins. This domain is composed of a nucleotide-binding oligomerization (NBO) domain and a leucine-rich repeat (LRR) domain.

The NBO domain is responsible for the binding of SNORD53 to specific DNA sequences, while the LRR domain is involved in the regulation of SNORD53's activity. Together, these domains give SNORD53 its unique structure and function.

SNORD53 is also known to play a role in the regulation of RNA stability and translation efficiency. This is done by its ability to interact with specific RNA-binding proteins (RBP), which are proteins that help to maintain the stability of RNA molecules in the cell.

In addition to its role in RNA regulation, SNORD53 is also involved in the regulation of gene expression in the brain. It has been shown to be involved in the regulation of neuronal differentiation, synaptic plasticity, and neurotransmission.

SNORD53 is also a potential drug target in the brain. Studies have shown that SNORD53 is highly expressed in human brain tissue and has been linked to cognitive function and neurodegenerative diseases. In addition, SNORD53 has also been shown to inhibit the overactivity of brain neurons associated with neurodegenerative diseases, thus providing a new idea for the treatment of these diseases.

In addition, SNORD53 has also been shown to be involved in regulating the differentiation and maturation of immune cells. This provides new ideas for studying the role of SNORD53 in immune cell function.

In summary, SNORD53 is a widely expressed protein with multiple functions, and it plays important roles in both the nervous system and the immune system. By studying SNORD53, we can better understand the interaction between the nervous system and the immune system and provide new ideas for the development of new drugs and treatments.

Protein Name: Small Nucleolar RNA, C/D Box 53

The "SNORD53 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD53 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets